The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam-Reference-Cited by-同舟云学术

The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam

Published:2014-02-15 Issue:15 Volume:231 Page:2967-2979
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Wright Brittany T.,Gluszek Catherine F.,Heldt Scott A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-014-3473-x.pdf

Reference122 articles.

1. Acikmese B, Haznedar S, Hatipoglu I, Enginar N (2012) Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats. Behav Pharmacol 23:215–219

2. Aitta-aho T, Vekovischeva OY, Neuvonen PJ, Korpi ER (2009) Reduced benzodiazepine tolerance, but increased flumazenil-precipitated withdrawal in AMPA-receptor GluR-A subunit-deficient mice. Pharmacol Biochem Behav 92:283–290

3. Ali NJ, Olsen RW (2001) Chronic benzodiazepine treatment of cells expressing recombinant GABAA receptors uncouples allosteric binding: studies on possible mechanisms. J Neurochem 79:1100–1108

4. Allison C, Pratt JA (2003) Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther 98:171–195

5. Allison C, Claase LA, Pratt JA (2002) Diazepam withdrawal-induced anxiety and place aversion in the rat: differential effects of two chronic diazepam treatment regimes. Behav Pharmacol 13:417–425

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment of cranial dystonia using a Zolpidem+Melatonin combination: A video case-series;Journal of the Neurological Sciences;2024-05

2. GABAA receptor subtypes and benzodiazepine use, misuse, and abuse;Frontiers in Psychiatry;2023-01-12

3. Antianxiety Medications: Are They Addictive or Are They Mankind’s Precious Heritage?;Psychopharmacology Reconsidered;2023

4. Three cases of difficulty in achieving definitive loss of consciousness with remimazolam;JA Clinical Reports;2022-01-11

5. Antipsychotic Medications;Handbook of Autism and Pervasive Developmental Disorder;2022